Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-19

Clinical Trial Update: Gene Expression Profiles to Categorize Wilms Tumors

View source ↗

Summary

The study evaluated using gene expression profiles to categorize Wilms tumors in children; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Oncology Group | Conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Stage I Wilms Tumor | Status: COMPLETED